307 related articles for article (PubMed ID: 32663913)
1. Squamous cell carcinoma of head and neck: what internists should know.
Jung K; Narwal M; Min SY; Keam B; Kang H
Korean J Intern Med; 2020 Sep; 35(5):1031-1044. PubMed ID: 32663913
[TBL] [Abstract][Full Text] [Related]
2. Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?
Caponigro F; Ionna F; Scarpati GDV; Longo F; Addeo R; Manzo R; Muto P; Pisconti S; Leopaldi L; Perri F
Anticancer Agents Med Chem; 2018; 18(9):1220-1227. PubMed ID: 29637868
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
5. [Current Standard of Care in Squamous Cell Carcinoma of the Head and Neck (SCCHN) - Prevention, diagnostics, prognostication and therapy].
Pogorzelski M; Grünwald V
Dtsch Med Wochenschr; 2019 Dec; 144(24):1691-1696. PubMed ID: 31791073
[TBL] [Abstract][Full Text] [Related]
6. CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).
Balermpas P; Rödel F; Rödel C; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Gkika E; Stuschke M; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Stangl S; Belka C; Pigorsch S; Multhoff G; Combs SE; Mönnich D; Zips D; Fokas E
Int J Cancer; 2016 Jan; 138(1):171-81. PubMed ID: 26178914
[TBL] [Abstract][Full Text] [Related]
7. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
[TBL] [Abstract][Full Text] [Related]
8. Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer.
Le X; Ferrarotto R; Wise-Draper T; Gillison M
J Natl Compr Canc Netw; 2020 Jul; 18(7):899-906. PubMed ID: 32634775
[TBL] [Abstract][Full Text] [Related]
9. Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.
van der Linden N; Buter J; Pescott CP; Lalisang RI; de Boer JP; de Graeff A; van Herpen CM; Baatenburg de Jong RJ; Uyl-de Groot CA
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):455-64. PubMed ID: 25876000
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Saloura V; Fatima A; Zewde M; Kiyotani K; Brisson R; Park JH; Ikeda Y; Vougiouklakis T; Bao R; Khattri A; Seiwert T; Cipriani N; Lingen M; Vokes E; Nakamura Y
Clin Cancer Res; 2017 Aug; 23(16):4897-4907. PubMed ID: 28442504
[No Abstract] [Full Text] [Related]
12. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
Mody MD; Gill HS; Saba NF
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
[TBL] [Abstract][Full Text] [Related]
13. Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
Singh P; Bennett B; Bailey T; Taylor-Stokes G; Rajkovic I; Contente M; Curtis S; Curtis C
BMC Cancer; 2021 Jul; 21(1):854. PubMed ID: 34303346
[TBL] [Abstract][Full Text] [Related]
14. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
[TBL] [Abstract][Full Text] [Related]
15. Exploring biomarkers in head and neck cancer.
Langer CJ
Cancer; 2012 Aug; 118(16):3882-92. PubMed ID: 22281752
[TBL] [Abstract][Full Text] [Related]
16. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
17. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G
Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
[TBL] [Abstract][Full Text] [Related]
19. Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck.
Guenne C; Fayette J; Cosmidis A; Fuchsmann C; Tartas S; Favrel V; Céruse P
Drug Des Devel Ther; 2014; 8():2549-53. PubMed ID: 25548517
[TBL] [Abstract][Full Text] [Related]
20. Evolving multidisciplinary treatment of squamous cell carcinoma of the head and neck in India
Anand AK; Agarwal JP; D'Cruz A; Dattatreya PS; Goswami C; Joshi A; Julka PK; Noronha V; Prabhash K; Rao RR; Kumar R; Toprani R; Saxena V
Cancer Treat Res Commun; 2021; 26():100269. PubMed ID: 33338859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
